Quest Diagnostics' consistent ROCE and increased capital employed over the past five years suggest steady reinvestment at good returns. This trend, reflected in the stock's strong performance, is expected to continue.
The acquisition aligns with Quest's strategy to grow through accretive outreach laboratory acquisitions and expands its ability to serve providers and patients in Ohio and Pennsylvania.
The CEO of Quest Diagnostics, Jim Davis, believes Yuri Fesko's deep medical expertise and patient-care advocacy will greatly contribute to the company's strategic decisions. His appointment especially bolsters Quest's efforts to improve customer experiences via diagnostic innovations.
Quest Diagnostics shows favorable metrics with robust reinvestment strategies. Significant earnings growth and an anticipated rise in future ROE, despite a higher payout ratio, hint at other growth factors.
Bruski2023ThirtyOne:
It’s really disgusting when you think about it…you’re a career politician with a net worth of 20-30-100mil, some way more. You absolutely have all the insight and information needed for the fuckery
The Covid-19 pandemic isn’t over but the U.S. is already entering a new vaccine boom. But the delayed vaccine rollout continues to raise questions. CNN reports that the U.S. delayed a large-scale vaccine order out of fear of the shots expiring before being administered. Federal agencies are exploring new ways to provide vaccines more efficiently, but the supply shortage poses challenges. For the U.S. government,...
chris from queens :
best comment for anyone reading this they will be pleasantly surprised if they are early to the party.... is a company that is very good in dealing with very infectious diseases and coming up with tests RAPID TEST! DYODD!!! $T2バイオシステムズ (TTOO.US)$
クエスト・ダイアグノスティックスに関するコメント
Senator Thomas Carper disclosed he profited shorting the US economy.
He became a millionaire many times over on a modest federal salary from trading.
Take a look:
Thomas Carper bought 30k in $ProShares Short QQQ(PSQ.US)$ , an ultrashort $インベスコQQQ 信託シリーズ1(QQQ.US)$ index, on July 13 2023.
He hedged/shorted in the past with great results with $Advisorshares Trust Ranger Equity Bear Etf(HDGE.US)$ , ...
The White House is about to turn to vaccine producers to curb the spread of monkeypox
コラムToday's pre-market stock movers: TSLA, T, NOK, UAL and more
In reaction to earnings/guidance:
• $スーパー・マイクロ・コンピューター(SMCI.US)$ +18%,$ノキア(NOK.US)$ +7.7%,$ダナハー(DHR.US)$ +6.3%,$RLI(RLI.US)$ +5%,$CSX(CSX.US)$ +4.3%,$ラスベガス・サンズ(LVS.US)$ +4.2%,$アルコア(AA.US)$ +3.4%(also authorizes new $500 mln share repurchase program)
• $スチール・ダイナミクス(STLD.US)$ +2.8%,$ハーク・ホールディングス(HRI.US)$ +2.6%,$テスラ(TSLA.US)$ +2.5%, $フィリップ モリス インターナショナル(PM.US)$ +2.5%,$FNB(FNB.US)$ ...
コラムToday's pre-market stock movers: TWTR, NIU, OCGN, SBUX and more
• $Twitter (Delisted)(TWTR.US)$ +20.5% (Elon Musk discloses 9.2% passive stake)
• $キャムテック(CAMT.US)$ +9.6%, $ペリオン・ネットワーク(PERI.US)$ +6.6% (In reaction to earnings/guidance)
• $ニウ・テクノロジーズ(NIU.US)$ +5% (reports QI sales volume increased 9.4% yr/yr)
• $Iron Spark I Inc(ISAA.US)$ +3.4% (Hypebeast plans to list on NASDAQ through Merger with Iron Spark I)
• $ガトス・シルバー(GATO.US)$ +2.3% (Provides Bi-Weekly Status Report)
• $ヴァーヴ・セラピューティクス(VERV.US)$ +1.8% (re...
コラムTop upgrades and downgrades on 4/4
• $DCP Midstream(DCP.US)$ : Evercore ISI Upgrades to Outperform from In Line - PT $42 (from $36)
• $レスリーズ(LESL.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $27 (from $26)
• $ロジテック・インターナショナル(LOGI.US)$ : Goldman Sachs Upgrades to Buy from Neutral
• $ニオ(NIO.US)$ : UBS Upgrades to Buy from Neutral - PT $32 (from $46)
• $オリーズ・バーゲン・アウトレット・ホールディングス(OLLI.US)$ : Wells Fargo Upgrades to Overweight from EqualWeight - PT $65 (from $45)
• $ORICファーマシューティカルズ(ORIC.US)$ : Citigro...
コラムS&P 500 Movers for Wednesday (1/12)
$NYダウ(.DJI.US)$ futures rose just 20 points. $S&P 500 Index(.SPX.US)$ futures gained 0.05% and $NASDAQ 100 Index(.NDX.US)$ futures rose 0.04%.
$テイクツー・インタラクティブ・ソフトウエア(TTWO.US)$$フリーポート・マクモラン(FCX.US)$$アプライド マテリアルズ(AMAT.US)$$テスラ(TSLA.US)$$モザイク(MOS.US)$
$バイオジェン(BIIB.US)$$Tロウ・プライス・グループ(TROW.US)$$クエスト・ダイアグノスティックス(DGX.US)$$ペリゴ(PRGO.US)$$アライン・テクノロジー(ALGN.US)$
まだコメントはありません